MedTrace Logo

Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation

NCT00387803 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 581

Last updated 2007-01-25

No results posted yet for this study

Summary

The purpose of this study was to determine if cardiac resynchronization therapy when combined with defibrillation is safe and effective in the treatment of symptomatic heart failure.

Conditions

  • Heart Failure, Congestive
  • Ventricular Fibrillation
  • Tachycardia, Ventricular

Interventions

DEVICE

Cardiac Resynchronization Therapy with Defibrillation

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Steven Higgins, MD · Scripps Memorial Hospital

  • Leslie A Saxon, MD · University of California San Francisco Medical Center

  • John Boehmer, MD · Milton S. Hershey Medical Center

  • Teresa De Marco, MD · University of California San Francisco Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-02-28
Completion
2001-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00387803 on ClinicalTrials.gov